Cleared Traditional

K141508 - ROMEO 2 PAD POSTERIOR AXIAL DEVICE (FDA 510(k) Clearance)

Aug 2014
Decision
76d
Days
Class 2
Risk

K141508 is an FDA 510(k) clearance for the ROMEO 2 PAD POSTERIOR AXIAL DEVICE. This device is classified as a Spinous Process Plate (Class II - Special Controls, product code PEK).

Submitted by Spineart (Geneva, CH). The FDA issued a Cleared decision on August 21, 2014, 76 days after receiving the submission on June 6, 2014.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3050. A Posterior, Non-pedicle Supplemental Fixation Device Intended For Single Level Use In The Non-cervical Spine (t1-s1). It Is Intended For Single Level Plate Fixation/attachment To Spinous Process For The Purpose Of Achieving Supplemental Fusion In The Following Conditions: Degenerative Disc Disease (defined As Back Pain Of Discogenic Origin With Degeneration Of The Disc Confirmed By History And Radiographic Studies), Trauma (i.e., Fracture Or Dislocation), Spondylolisthesis, And/or Tumor. It Is Not Intended For Stand-alone Use..

Submission Details

510(k) Number K141508 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 2014
Decision Date August 21, 2014
Days to Decision 76 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code PEK — Spinous Process Plate
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3050
Definition A Posterior, Non-pedicle Supplemental Fixation Device Intended For Single Level Use In The Non-cervical Spine (t1-s1). It Is Intended For Single Level Plate Fixation/attachment To Spinous Process For The Purpose Of Achieving Supplemental Fusion In The Following Conditions: Degenerative Disc Disease (defined As Back Pain Of Discogenic Origin With Degeneration Of The Disc Confirmed By History And Radiographic Studies), Trauma (i.e., Fracture Or Dislocation), Spondylolisthesis, And/or Tumor. It Is Not Intended For Stand-alone Use.